Please wait.'

Page is loading'


Home  > Markets & companies  > Evonik is investing into its US Specialty...

Saturday, 21 April 2018
pdf
Markets & companies

Evonik is investing into its US Specialty Methacrylate plant

Monday, 16 April 2018

Evonik is expanding its production capacities for methacrylate crosslinkers of the Visiomer brand with an investment in the low single-digit million-euro range.

Evonik invests in its methacrylates business in the USA. Source: Evonik.

Evonik invests in its methacrylates business in the USA. Source: Evonik.

The Methacrylates Business Line has made the investment at the Mobile site (Alabama, USA). The start-up is scheduled for the third quarter of 2018. "With this investment, we will further improve the global positioning of Application Monomers. It will allow us to provide customers with crosslinkers from our plants in the US, Germany, and China,” explains Hans-Peter Hauck, head of the Methacrylates Business Line in the Performance Materials Segment.

Development of the methacrylates business

"In the future, we will be able to provide methacrylate crosslinkers for the US market out of Mobile plant,” continues Grant Lafontaine, general manager of the Application and Bulk Monomers Product Lines in the US. "We will thereby significantly improve our flexibility and responsiveness for the benefit of our customers in the US.”
Evonik is currently looking for the best owner for its methacrylates business, which is being set up as an independent entity. The aim is to find a new owner who will invest in the long term growth of the methacrylates business.

top of page
Comments (0)
Add Comment

Post comment

You are not logged in

register